|

Phase II-Advanced melanoma Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Tyligand Bioscience (Shanghai) Limited1

Indications

  • Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma1
  • Cancer1

Other1 trial

TSN222 in Subjects With Advanced Solid Tumors or Lymphomas
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.